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Summary The EUROCLUS project included information on residence at diagnosis for 13 351 cases of childhood leukaemia diagnosed in the
period 1980-89 in defined geographical regions in 17 countries. A formal algorithm permits identification of small census areas as containing
case excesses. The present analysis examines spatial-temporal patterns of the cases (n = 970) within these clustered areas. The objectives
were, first, to compare these results with those from an analysis conducted for UK data for the period 1966-83, and, second, to extend them
to consider infant leukaemias. A modification of the Knox test investigates, within the small areas, temporal overlap between cases in a
subgroup of interest at a putative critical time and all other cases at any time between birth and diagnosis. Critical times were specified in
advance as follows: for cases of acute lymphoblastic leukaemia aged 2-4 years, the 18-month period preceding diagnosis; for cases of total
leukaemia aged 5-14 years, 1 year before to 1 year after birth; and for infant cases (diagnosed < 1 year), 1 year before to 6 months after
birth. Each of the analyses found evidence of excess space-time overlap compared with that expected; these were 10% (P = 0.005), 15%
(P = 0.0002) and 26% (P = 0.03) respectively. The results are interpreted in terms of an infectious origin of childhood leukaemia.
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Leukaemia is the most frequent childhood malignancy (Parkin et
al, 1988), but the cause of the majority of cases remains unknown
(Doll, 1989). Reports of clusters of leukaemia, usually involving
children, have been frequent throughout this century (Alexander,
1993), but their aetiological significance remains obscure. The
EUROCLUS project (Alexander et al, 1996) was established to
investigate the geographical pattern of the disease using specialist
registry data from a wide spectrum of European countries, and also
from Queensland, Australia. The primary objective was to deter-
mine whether the disease showed a general tendency to cluster
within small areas. The results (Alexander et al, 1998) show statis-
tically significant evidence of clustering, although the magnitude
is small. The only previous investigation of spatial clustering of
childhood leukaemia (CL) in a large dataset was conducted in the
UK (Draper, 1990). This, too, reported statistically significant
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evidence of weak clustering. The UK analysis was subsequently
extended to examine temporal patterns of cases within the areas
that showed most evidence of clustering to test two specific prior
hypotheses (Alexander, 1992), namely (a) that exposure to
common infectious agents at certain critical times may cause CL;
and (b) that the relevant exposures often occur in the context of a
microepidemic in the geographical population; the origin and
justification of these hypotheses are reviewed in Greaves and
Alexander (1993) and Kinlen (1995). A second objective of
EUROCLUS was to test these hypotheses and make comparisons
with the results of the UK analysis (Alexander, 1992). Specific
subgroups of interest are (a) cases of acute lymphoblastic
leukaemia (ALL) in the childhood peak, and (b) cases of CL aged
5-14 years. Critical times, specified in advance are for (a) the
18-month period preceding diagnosis, and for (b), 1 year before to
1 year after birth.
A third subgroup of interest that had not been included in the
UK analysis is infant leukaemia (diagnosed < 1 year or < 18
months), which has recently emerged as an interesting biological
entity as a large proportion of these cases have rearrangement of
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the MLL gene (Kumar, 1993). Because these rearrangements are
rare in older subjects, except in cases of secondary leukaemia after
epipodophyllotoxin therapy, it has been hypothesized that environ-
mental exposures that, like the epipodophyllotoxins, inhibit the
action of topoisomerase II may cause infant leukaemias (Ford et
al, 1993; Ross et al, 1994). Twin studies have demonstrated that
infant cases with MLL rearrangements arise in utero (Ford et al,
1993). Thus, the prevailing hypotheses for infant leukaemia,
unlike those for older cases, do not relate to exposure to infectious
agents. However, as the statistical significance of the EUROCLUS
results depended on the inclusion of the infant cases (Alexander et
al, 1998) the analyses were extended to include infants.
METHODS
The method of analysis of spatial clustering applied to the EURO-
CLUS data was the Potthoff-Whittinghill method (Muirhead and
Butland, 1996). The test statistic is based on the sum of statistics
calculated for each small census area as 0(0 - 1)/E, where 0 and
E are the observed and expected numbers of cases. This does not
lend itself to ranking of areas with highly variable values of E as
the largest values can occur in areas with large populations but
with a deficit of observed compared with expected. Alternative
methods of ranking based on OIE and the Poisson P-values have
been used conventionally, but encounter similar problems in that
they are highly sensitive to variations in the expected numbers. A
methodological study conducted for EUROCLUS (submitted)
identified an alternative ranking statistic [0(0 - 1)/E - El that was
superior in terms of sensitivity and specificity in identifying clus-
tered areas. This has been used (see Appendix 1) to select up to 25
areas in each geographical region as being the most clustered.
These areas form the basis of the present study. They have also
been compared with 'control' areas; significant differences for
population mixing and other demographic factors previously
associated with CL (Kinlen, 1995) provide confirmation that the
algorithm selects for study areas that are aetiologically meaningful
(Alexander et al, submitted).
The present study population consists of all cases of CL diag-
nosed in the period 1980-89 in the areas defined as clustered in 14
countries that participated in this phase of EUROCLUS. These
cases were divided into two diagnostic groups - ALL and other
leukaemias. Cases of non-Hodgkin's lymphoma were ascertained
for EUROCLUS, primarily for purposes of quality control; they
were occasionally used in the selection of cluster areas (see
Appendix 1), but have not been included in the present analysis.
Three analyses have been conducted corresponding to different
definitions of diagnostic group, age at diagnosis and period of risk
of a critical group (series A1-A3) specified in advance.
Series Al
Cases of ALL aged 2-4 years at diagnosis with risk period the 18-
month period before diagnosis (or age 12 months to diagnosis if
that is shorter). This group is defined in such a way as to represent
the childhood peak of ALL, and also to ensure that the risk period
was entirely distinct from the time around birth.
Series A2
Cases of childhood leukaemia aged 5-14 years at diagnosis with
risk period from 1 year before to 1 year after birth.
Series A3
Cases of infant leukaemia (diagnosed < 12 months) with risk
period surrounding the time in utero: specifically 12 months
before birth to 6 months after birth.
Linkages of children in series Al with those in series B (all
cases of CL in the clustered areas) were identified; these linkages
can be of time and/or space. Two distinct cases, one taken from
each series are linked in time if the risk period of the series Al case
overlaps the period from the date of conception (taken as date of
birth -12 months) to date of diagnosis of the series B case by at
least 3 months, and in space if the places of residence when
diagnosed were in the same small area.
Similar analyses were carried out for series A2 and A3.
The overlap of 3 months is intended to reflect the fact that
epidemics are not localized to just one moment in time. As linkage
in time requires this overlap, the risk periods specified for each of
Series A1-A3 extend the biologically most plausible periods of
risk of exposure by around 3 months in each direction (for example
the in utero risk period is taken to begin 12 months before birth, the
prediagnosis risk period ends at diagnosis, although a few months
must elapse between the causative exposure and diagnosis).
The analysis involves computation of the numbers of cases that
are linked in both space and time after allowing for the numbers of
cases linked separately in time or space (Knox, 1964). These link-
ages for pairs of cases for each country/region are shown diagram-
matically below:
Linked in time
Yes No
Linked in space Yes a b
No c d
T N-T
S
N-S
N
The expected number (E) of pairs linked in both space and time
under the null hypothesis of no space-time interaction is ST/N. In
the classical Knox test, there is just one series of cases and one
time of risk and a is compared with E, using the approximating
Poisson distribution or a permutation or Monte Carlo test in which
S, T and N are all held fixed. The present analysis uses a modifica-
tion of the Knox test identical to that of Alexander (1992). This
uses a Monte Carlo procedure; the array of dates of birth/dates of
diagnosis pairs of the entire study population were randomized
within diagnosis group within country/region while keeping the
small area of diagnosis arrays fixed. The numbers of cases in both
diagnostic groups are thus held constant for individual small areas.
Within each country/region, the following also remain constant:
(a) the number of cases in each series, (b) the total number (N) of
pairs of cases, (c) the number of these pairs (T) linked in time, (d)
the age, time of birth and time of diagnosis distributions for each
diagnostic group. However, the number of cases in series Al (or
A2, A3) in individual small areas will change and so the number of
space linkages (S) and hence E will vary [The randomization could
have been applied separately to age groups within ALL, ANLL
that would have kept S fixed but the methodology of Alexander
(1992) has been followed precisely. This also allows the use of
identical randomization procedures in each analysis.] Monte-Carlo
testing has been applied to the standardized Z statistic of the Knox
test that takes account of this:
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Z = (O-E)
where 0 is the observed number and E the expected number of
space-time linkages summed over countries/regions.
Although no assumptions are required for the analysis of the
space-time data, it is prudent to apply two simple assumptions
when interpreting the results in terms of exposure to an infection
occurring at the place of residence (see also, Smith et al, 1976;
Alexander, 1992).
Assumption 1: The children have lived in the same small area
throughout the time from birth to diagnosis (and their mothers
have lived there during the relevant pregnancies).
Assumption II: A child who will subsequently be diagnosed
with leukaemia is a marker of risk of exposure to a causative
infection in the area in which he/she is currently living.
Under these assumptions, excess space-time interactions for
analyses of series Al, A2 are testable predictions of prior
hypotheses of infectious aetiologies for CL. Strictly, they are only
required for children involved in space-time interactions at the
(unknown) time of their aetiological exposures.
RESULTS
The cases in the study population (Tables 1 and 2) are from 14
countries and show the usual high frequency of ALL at the child-
hood peak ages. Two countries (Switzerland and France) had fewer
than 25 areas meeting the threshold for selection as clustered. The
remainder all had 25 areas selected but the size (in terms of popula-
tion at risk) of the areas varied by country and, in consequence, the
number of cases is quite variable. The proportion of infant cases in
the clustered areas is slightly higher than in the total dataset.
Results (Tables 3 and 4) show, for analyses of series Al and A2,
highly significant overall excesses of pairs linked in both space
and time. The patterns are qualitatively present in the majority of
individual countries, although certain ones are particularly influ-
ential: Spain, UK and Italy for series Al; and Australia and Spain
for series A2. Results for Europe remain statistically significant. A
small number of countries have a deficit of space-time pairs; these
include Germany and Sweden for series Al and Norway for series
A2. Excess space-time pairs are seen for countries that did not
show evidence of generalized clustering (Alexander et al, 1998) as
well as those that did.
For series A3 (infant cases), the number of cases was much
smaller and, in consequence, statistical power was reduced. The
results (Table 5) show a larger and statistically significant
percentage excess (26%) of observed to expected space-time pairs
with individual excesses in each country apart from England and
Wales based, often, on very small numbers.
Thus, the temporal distributions of the cases diagnosed in the
clustered areas were non-random. Analyses for other definitions of
series A, specifically, other sets of critical periods (in particular,
young ALL cases around the time of birth, and older cases close to
diagnosis) did not reveal evidence of space-time linkage.
DISCUSSION
One clear conclusion follows from the present results: testing for
the predicted space-time patterns has confirmed their presence and
Table 1 Cases included, by age group and diagnosis
ALL Other leukaemia Total
Infants < 1 year 33 21 54
Others < 4 years 469a 44 513
5-14 years 347 56 403
Total 849 121 970
aOne case in Sweden excluded as duplicate value of id, date of birth, area.
This may be a duplicate case or a twin but in either event it is conservative to
exclude from these analyses.
Table 2 Cases included by country
Country Total ALL Total Infants
number 2-4 years leukaemia
5-14 years
Australiaa 77 37 33 3
Denmark 94 42 37 6
England and Wales 69 37 19 4
Finland 93 36 41 4
Franceb 18 6 9 0
Germany 77 29 35 5
Greece 94 44 36 4
Italyc 58 19 33 1
Netherlands 114 53 43 5
Norway 70 31 30 2
Scotland 72 31 27 7
Spaind 41 13 18 7
Sweden 84e 27 36 6
Switzerlandf 9 2 6 0
aQueensland; bC6te D'Or; cPiedmont; dValencia. eOne case in Sweden
excluded since duplicate value of id, date of birth, area. This may be a
duplicate case or a twin, but in either event it is conservative to exclude from
these analyses. 'Vaud and Neuchatel.
Table 3 Space-time interactions: analysis of series Al a
Country Observed Expected Standardized Per cent
z excess
Australia 45 41.99 0.47 7.2
Denmark 56 53.75 0.31 4.2
England and Wales 32 25.24 1.35 26.8
Finland 51 42.88 1.24 18.9
France 6 5.65 0.15 6.3
Germany 23 25.33 -0.46 -9.2
Greece 88 83.14 0.53 5.8
Italy 19 15.29 0.95 24.3
Netherlands 110 101.04 0.89 8.9
Norway 26 25.97 0.00 0.1
Scotland 29 22.52 1.37 28.8
Spain 9 6.38 1.04 41.2
Sweden 31 31.57 -0.10 -1.8
Switzerland 1 0.94 0.06 6.7
Europeb 481 434.69 2.22 10.7
All countriesc 526 476.20 2.28 10.5
aALL cases aged 2-4 years; time at risk, 18 months preceding diagnosis;
bMonte Carlo P-values (based on 9999 runs), 0.0046; cMonte Carlo P-values
(based on 9999 runs), 0.0050.
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Table 4 Space-time interactions: analysis series A2a
Country Observed Expected Standardized Per cent
z excess
Australia 49 30.50 3.35 60.6
Denmark 52 41.92 1.56 24.0
England and Wales 14 10.92 0.93 28.3
Finland 54 52.70 0.18 2.5
France 7 6.59 0.16 6.3
Germany 31 24.35 1.35 27.3
Greece 49 45.56 0.51 7.5
Italy 18 17.60 0.10 2.3
Netherlands 61 56.75 0.56 7.5
Norway 17 19.86 -0.64 -14.4
Scotland 19 16.37 0.65 16.1
Spain 9 5.63 1.42 59.9
Sweden 40 35.65 0.73 12.2
Switzerland 3 3.00 0.00 0.0
Europeb 374 337.66 1.98 10.8
All Countriesc 423 368.75 2.82 14.7
aAll leukaemias, age 5-14 years; time at risk, date of birth ± 1 year; bMonte
Carlo P-values (based on 9999 runs), 0.0038; cMonte Carlo P-values (based
on 9999 runs), 0.0002.
Table 5 Space-time interactions: analysis series A3a
Country Observed Expected Standardized Per cent
z excess
Australia 3 2.26 0.49 32.6
Denmark 12 9.08 0.97 32.2
England and Wales 1 2.00 -0.71 -50.0
Finland 4 3.62 0.20 10.6
France Not applicableb
Germany 6 4.37 0.78 37.4
Greece 5 4.16 0.41 20.2
Italy 1 0.65 0.44 54.1
Netherlands 8 6.49 0.59 23.3
Norway 5 4.87 0.06 2.7
Scotland 6 4.39 0.77 36.5
Spain 2 1.69 0.24 18.6
Sweden 10 7.78 0.80 28.6
Switzerland Not applicableb
Europec 60 47.47 1.82 26.4
All countriesd 63 50.01 1.84 26.0
alnfant cases (diagnosed < 1 year old); time at risk, from 12 months before
birth to 6 months after birth; bno cases in Series A3; cMonte Carlo P-values:
(based on 9999 runs), 0.041; dMonte Carlo P-values (based on 9999 runs),
0.032.
the evidence is highly statistically significant. The results confirm
those previously reported for ALL in UK data. The method,
although based on that of Knox, addresses more specific aetiolog-
ical hypotheses and is also more complex than tests of space-time
clustering using time and place of diagnosis. The last tests have
been applied widely to CL with somewhat equivocal conclusions
(for example van Steensel-Moll et al, 1983) and positive results
most frequent for young children (0-4 years) (Alexander, 1993).
The Knox test has not been applied to the present data, with the
exception of Greece where marked space-time interaction was
observed for this youngest age group (Petridou et al, 1996).
As many animal leukaemias are caused by viruses (Onions,
1985) and some related human conditions by viruses and bacteria
(Robert-Gurroff and Gallo, 1983; Wotherspoon et al, 1993;
Schultz and Neil, 1996), the hypothesis that childhood leukaemia
is caused by similar exposures is plausible. Studies by Kinlen and
colleagues (reviewed in Kinlen, 1995) are difficult to explain,
except in terms of increase in risk of leukaemia consequent upon
exposure patterns that pertain when herd immunity is dysregulated
by population mixing. These studies provide little guidance
concerning critical times of exposure. Other epidemiological data
provide persuasive, although indirect, evidence to support the
hypothesis (Greaves and Alexander, 1993; Greaves, 1997) that
delayed first exposure to an unknown infectious agent (or agents)
may cause ALL at the childhood peak ages. The evidence includes
the evolution of the peak as societies 'modernize', and increased
risk for children likely to have been protected from early infection
relative to their peers - with increases in firstborn children
(Fraumeni and Miller, 1967), those substantially younger than
their siblings (Kaye et al, 1991), those living in isolated areas
(Alexander et al, 1990), and decreases in those hospitalized for
infectious disease as infants (van Steensel-Moll et al, 1986) and
those attending preschool groups as infants (Petridou et al, 1993).
Series Al was chosen to address the above hypothesis.
The second hypothesis of interest is that in utero or neonatal expo-
sure to an infectious agent or agents contributes to CL in older chil-
dren. The justification for this and the selection of series A2 in the
original analysis (Alexander, 1992) were considerably weaker; they
came directly from the analysis of residential histories in two
case-control studies (Smith et al, 1976; Alexander et al, 1992) with
indirect support coming from comparisons of the ages of the persons
most likely to have been involved in mixing with the ages of the
subsequent leukaemia excess in Kinlen's studies in which, in general,
mixing of adults is associated with excess CL outside the childhood
peak ages (reviewed in Alexander, 1993). Mixing of adults will most
obviously influence children in utero or during early life.
To test these hypotheses using the present study design, some
assumptions are required (see Methods). Assumption I is unlikely to
be precisely true: some of the children will have moved between
birth and diagnosis and, in particular, between contact with a
causative infection and diagnosis. However, we have selected areas
in which the excess leukaemia risk is likely to have a degree of
permanence (indicated by the excess incidence calculated over a 10-
year period) and in which, if the area has any aetiological signifi-
cance, (most of) the affected children would have been living when a
critical exposure occurred. The same selection of areas was applied
for the same reason in the earlier analysis (Alexander, 1992).
We turn now to Assumption II. If infectious organisms can
contribute to (some) cases of childhood leukaemia, then these
cases will have been exposed at some time before their diagnosis.
For some, perhaps most, of these children, exposure will have
occurred in the area in which they were then living. It is reasonable
to suppose that the opportunity for exposure of other children
living in that area was increased at the same time. The child would
be a marker of excess risk of exposure in the local community at
this (unknown) point in time. As the time cannot be identified and
latent periods may be highly variable, it is prudent to interpret this
as marking excess risk 'on average' over the entire time from
conception to diagnosis. This provides support for Assumption II,
although social mobility will lead to exposures elsewhere.
Selection of high-risk areas should, as has been argued above,
minimize this. We note that the assumptions are strictly required
only for a limited set of cases at specific times.
The present results, taken together with those of Alexander
(1992) are, at least, consistent with the hypotheses outlined above
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and it is reasonable to argue that they offer support for them. If so,
they suggest that the agents need not be age- nor subtype-specific,
although critical times of exposure may well be specific. For the
childhood peak of ALL, they point to post-natal rather than to
in utero exposure, which has been proposed by Smith, 1997.
Other explanations for the present findings are certainly possible
but rather contrived. These include ones involving environmental
'accidents' (i.e. short-term release of chemical or other pollutants).
Exposures to cyclical epidemic infections could possibly be
involved. Other analyses have indicated that a small number of the
clustered areas are near to environmental hazards previously
associated with increased incidence of CL (EUROCLUS, 1997).
Further clarification of these findings (in the absence of identifi-
cation of causative agents) will require analyses of complete resi-
dential histories and these are in progress.
Analyses of infant cases (series A3) were not included in the
previous study but the results are statistically significant and the
percentage excess of space-time linkages both large and concen-
trated. Although exposure to infections is not often considered as a
factor in the aetiology of infant leukaemia, one of Kinlen's studies
found an excess only for children under the age of 2 years and the
largest excess was for infants (Kinlen and Hudson, 1991); as noted
above, EUROCLUS found infants to be intrinsically involved in
spatial clustering, but the MLL status of the infant cases is
unknown. Thus, the present results cannot be interpreted as indica-
tive of an infectious aetiology for infant leukaemias having MLL
gene rearrangements. They do nevertheless point to sharing of
aetiological exposures by at least a minority of infant leukaemias
with older cases and suggest that these exposures may be to
common infectious agents. Characterization of the relevant infant
subgroup must be an important research priority.
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APPENDIX 1: SELECTION OF CLUSTERED
AREAS
Selection was performed on an individual country (or region) basis
and was limited to areas with between 0.1 and 5.0 expected cases of
total childhood leukaemia in the period 1980-89. This criterion was
chosen to exclude both extremely small and extremely large areas.
For each diagnosis group [acute lymphoblastic lymphoid
leukaemia (ALL) and total childhood leukaemia (CL) at ages 1-7
years, 0-4 years, 0-14 years and lymphoid leukaemia/non-
Hodgkin's lymphoma (LL/NHL) at ages 0-14 years] within each
area the value of the ranking statistic
W= 0(0-1)
E-E
was calculated and allocated to a value category (> 28, 20-28,
14-20, 10-14, 8-10, 6-8, 4-6, 2-4, 0-2). The use of W as ranking
statistic for the selection of clustered areas was justified by a
methodological study conducted for EUROCLUS (Wray et al,
submitted). Values of W < 0 were not included in the ranking. The
maximum value of W differed between countries - from 15
(Denmark) to 106 (England and Wales). Area diagnosis groups that
were in the same W-category were ordered by the P-value of the
Potthoff-Whittinghill test for the country/region and diagnostic
group (categories being < 1%, 1-5%, 5-10%, > 10%). Finally, any
area diagnosis groups that were in the same W-category and P-value
category were ordered by age-diagnostic group priority (based on
prior hypotheses). These were ALL 1-7 years, ALL 0-4 years, CL
1-7 years, CL 0-4 years, ALL 0-14 years, Th 0-14 years,
AL1INHL 0-14 years. This provided an unambiguous ranking of
selected small areas - diagnosis groups pairs in each country/region
with no ties. The first 25 areas occurring in this list were selected as
clustered areas for the country/region (some areas were ranked
highly for several diagnosis groups). Smaller numbers of areas were
selected when a country/region had < 25 areas with W> 0 (Cote
d'Or, France and Vaud and Neuchatel, Switzerland).
APPENDIX 2: COLLABORATORS IN THE
EUROCLUS PROJECT
Australia Cancer Registry of Queensland
DrW McWhirter
Denmark Danish Cancer Registry
Dr H Storm
Dr JH Olsen
England and Wales Childhood Cancer Group
Dr GJ Draper
Dr CA Stiller
Estonia Department of Epidemiology and
Biostatistics
Institute of Experimental and
Clinical Medicine
Professor M Rahu
Finland Finnish Cancer Registry
Dr E Pukkala
Dr L Teppo
France Registry of Haematopoietic
Malignancies
Professor PM Carli
Dr G Couillault
DrM Maynadie
Germany National Register of Childhood
Malignancies
Professor Dr J Michaelis
Dr I Schmidtmann
Greece Special Data Collection
Dr E Petridou
Italy European Institute of Oncology
Professor P Boyle
Childhood Cancer Registry of
Piedmont
Professor B Terracini
Dr C Magnani
Netherlands Dutch Childhood Leukaemia Study
Group
Dr A Van Der-Does-Van Den Berg
Department of Epidemiology and
Biostatistics,
Erasmus University
Dr JW Coebergh
Norway Norwegian Cancer Registry
Dr L Vatten
Scotland Co-ordinating Centre
Dr F E Alexander
Dr N Wray
Scottish Cancer Registry
Dr D Brewster
Dr P McKinney
Slovakia The National Cancer Registry of
Slovakia
Dr I Plesko
Slovenia Cancer Registry of Slovenia
Professor Dr V Pompe-Kirn
Spain Childhood Tumour Registry of
Valencia
Dr R Peris-Bonet
Sweden Department of Cancer
Epidemiology, University of
Uppsala
Dr H-O Adami
Dr A Ekbom
Swedish Cancer Registry
Dr J Bring
Switzerland Registres Vaudois et Neuchatelois
des Tumeurs
Dr F Levi
C) Cancer Research Campaign 1998 British Journal of Cancer (1998) 77(5), 812-817
